RxDoctor Payments Data

Ian McNeill

Neurological Surgery · Farmington, CTNPI 1003158486

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (42.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Globus Medical at 43.6% of the total. Reporting peaked in 2020 at $10,000 and has fallen 77.7% since, to $2,230 in 2025.

$23,734in general payments, 2019–2025

Across 103 payments — averaging $230.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$10K
  • Stryker$7K
  • Alphatec Spine, Inc$4K
  • Medtronic$604
  • Augmedics Inc.$401
  • Spineology Inc.$398
  • plus $2K from 12 others

What the payments were for

  • Grants$10,00042%
  • Travel & lodging$6,27626%
  • Food & beverage$7,45831%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,734 in reported general payments places this provider in the 75th percentile of 94 neurological surgery providers in Connecticut.

See all neurological surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$94,343
Medicare patients
79
Services billed
314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin35$750
Lidocaine12$718
Methocarbamol33$632
Celecoxib12$374
Cyclobenzaprine Hcl23$192
Methylprednisolone13$168
Pregabalin13$152

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Farmington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →